Atlas Trials

A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy

Clinical trial NCT07468851 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07468851
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
High-risk Non-muscle-invasive Bladder Cancer
Start date
2026-06-10
Primary completion
2028-04-30
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.